Zebra Technologies' analyst fair value estimate has shifted from $263.00 to $292.02, as analysts adjust their targets after recent research pointed to a 2026 growth reacceleration and sector tailwinds in areas like data centers, factory and warehouse automation, and semiconductors.
Analyst Commentary
Recent Street research on Zebra Technologies shows a mix of optimism around the 2026 outlook and caution around nearer term execution and growth visibility. While some large firms have lifted their fair value targets, other bearish analysts have trimmed theirs and highlighted risks that readers should keep in mind.
Bearish analysts have focused on the implications of the latest quarterly update, where questions around organic growth rates led to more conservative assumptions for how quickly demand could firm up. These views sit alongside more constructive takes from houses like Morgan Stanley and Barclays that reference a 2026 industrial technology and distribution outlook and potential sector tailwinds across areas such as data centers, factory and warehouse automation, electronics, test and measurement, and semiconductors.
Bearish Takeaways
- Bearish analysts who lowered price targets point to uncertainty around the timing and strength of any growth reacceleration, especially after earlier concerns tied to organic growth in the most recent quarter, which can pressure valuation if execution does not line up with Street expectations.
- Repeated target revisions around the same time, including both raises and cuts, signal that the earnings and growth path is still being recalibrated, which can introduce additional risk for readers who rely on stable estimates when thinking about entry points or position sizing.
- Price target cuts from bearish analysts indicate more conservative assumptions on end market demand and execution, which can cap upside in scenarios where Zebra hits only the middle of current Street expectations rather than the more optimistic 2026 scenarios.
- The range between higher targets from firms like Morgan Stanley and earlier lower targets from bearish analysts reflects a wide dispersion in views on growth and valuation, reminding readers that outcomes could differ meaningfully from central estimates if growth, margin performance, or capital allocation track closer to the cautious camp.
What's in the News
- Zebra authorized a new share repurchase plan on February 4, 2026, alongside a separate authorization to buy back up to US$1,000 million of common stock with no stated expiration date (Buyback Transaction Announcements).
- From September 28, 2025 to February 5, 2026, Zebra repurchased 1,578,887 shares, or 3.11% of its stock, for US$402.5 million, completing a total of 3,082,195 shares, or 6.04%, for US$841.85 million under the May 17, 2022 program (Buyback Tranche Update).
- The company issued earnings guidance for 1Q26, indicating expected sales growth of 11% to 15% year on year, and for full-year 2026, expecting 9% to 13% sales growth, with acquisitions and FX contributing an estimated 10 points and 7 points, respectively (Corporate Guidance: New/Confirmed).
- Zebra plans to showcase its Orchestrated Care framework at HIMSS26 in March 2026, highlighting intelligent visibility, empowered teams, and optimized operations in healthcare, supported by devices such as the new DS82 HC Series scanner (Product-Related Announcements, HIMSS26).
- At NRF 2026, Zebra is set to feature new AI driven retail solutions, including TC501 and TC701 handhelds, the ET401 enterprise tablet with integrated RFID, a modular ShareCradle charging system, Salesforce Retail Cloud POS on Zebra devices, a device rental service, and updates to Zebra Workcloud Sync and Task Management (Product-Related Announcements, NRF 2026).
Valuation Changes
- Fair Value Estimate was moved from $263.00 to $292.02, representing a moderate upward reset in the analyst fair value anchor.
- The Discount Rate was lifted from 7.96% to 9.01%, implying a higher required return applied to Zebra Technologies' future cash flows.
- Revenue Growth was adjusted from 5.10% to 6.71%, reflecting higher modeled top line growth in the updated assumptions.
- Net Profit Margin was reduced from 12.12% to 10.01%, indicating lower expected profitability on each dollar of revenue in future years.
- Future P/E increased from 22.07x to 25.35x, suggesting a higher earnings multiple embedded in the refreshed valuation work.
Have other thoughts on Zebra Technologies?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.